AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
164.50
0.00 (0.00%)
Sep 7, 2025, 8:00 PM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $251.37 billion as of September 9, 2025. Its market cap has decreased by -6.87% in one year.
Market Cap
251.37B
Enterprise Value
276.99B
Revenue
56.50B
Ranking
n/a
PE Ratio
30.30
Stock Price
$164.50
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 251.37B, an increase of 3,439.95%. That is a compound annual growth rate of 11.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 253.68B | 24.86% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | 131.26B | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |